Paydirt
JP
Insider

Jason Pitofsky

VP Controller

Jason Pitofsky (VP Controller) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $1.4M of REGN (1,824 sh across 5 lots, as filed), executed Feb 9.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Feb 9
Filed Feb 11

Median ADV $702.3M across their filed names

Open performance
Volume by month
$1.4M$710K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2025 · sells $281KFeb 2026 · sells $1.4M
Buys $0 Sells $1.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
REGN Regeneron Pharmaceuticals, Inc. REGN · 0 buys · 2 sells 2 filings
Recent filings
REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $1.4M
1,824 sh across 5 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET
REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $281K
431 sh × $651.43
Exec Nov 7 2025
Filed Nov 10 2025 · 5:30 PM ET